Reveleer

www.reveleer.com

VCMatch tracks Reveleer as an investor focused on AI/ML, Vertical SaaS, and Digital Health companies and United States markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Not specified

Focus Areas

AI/ML, Vertical SaaS, Digital Health

Geography

United States

Investment Thesis

Reveleer invests in building a unified, AI-first SaaS platform that consolidates fragmented clinical data and workflows to drive measurable improvements in value-based care. The firm prioritizes explainable, hybrid AI plus deep domain expertise to automate retrieval, risk adjustment, quality improvement, and member management so payers and providers can realize operational, clinical, and financial ROI while remaining audit-ready and compliant.

Is Reveleer right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Reveleer is most relevant for founders raising venture-backed rounds in AI/ML, Vertical SaaS, Digital Health, and Data Infrastructure, especially across United States.

Focus statement

Focused on value-based care technology: an end-to-end, cloud-native platform combining clinical intelligence, risk adjustment, quality improvement, enrollment/member management, and RADV audit readiness powered by proprietary and hybrid AI.

Value Add

End-to-end unified platform that "consolidates every piece of data you capture" across retrieval, clinical intelligence, risk adjustment and quality improvement (reduces reliance on multiple vendors).
Proprietary Evidence Validation Engine (EVE™) and hybrid AI that "combines Gen AI with clinician-authored logic" to deliver "provable, explainable diagnosis suspecting at scale."
Demonstrated scale and throughput: claims on processing "more than 70M medical documents annually", "processes more than 1.1 billion pages of data annually", and supporting "5.5M annual chart reviews."
Audit and regulatory expertise: long experience with RADV/HHS IVA ("certified auditor since the program's inception") and tooling built to streamline RADV audit steps and defensibility.
High accuracy and measurable outcomes: "Our proprietary AI-scoring model delivers up to 99% coding accuracy" and cited ROI metrics (e.g., "$18.5+ million enhanced revenue capture", "40% increase in value per chart").
Bi-directional EHR and HIE integrations ("seamlessly connects with more than 45 EHRs") to surface pre-encounter longitudinal patient compendia in provider workflows.
Blended product + services model: platform-first SaaS with optional deep professional services (retrieval, abstraction, audit support) to accelerate time-to-value.